Interesting Finding: Reduced Alcohol Cravings Interestingly, recent research has found that GLP-1 medications may actually reduce alcohol cravings and consumption in some individuals: Studies have shown that both semaglutide (GLP-1 agonist) and tirzepatide (GLP-1/GIP combination) appear to effectively reduce alcohol consumption in individuals with obesity
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43
Navarro recommends using a non-abrasive exfoliating wash, such as the ZO Exfoliating Cleanser and the Neostrata Exfoliating Wash, starting with once a day usage for two to three weeks then gradually building up to twice or thrice weekly
Semaglutide treatment is suitable for a variety of individuals, particularly those who: Have been diagnosed with type 2 diabetes and are struggling to manage their blood sugar levels with diet, exercise, and other medications
The best time of day to take tirzepatide for weight loss is not specified by FDA guidelines, as clinical evidence shows the medication works effectively regardless of when you inject it